Search for: "In Re Lockheed Martin Corp. Securities Litigation"
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
8 Oct 2017, 4:37 pm
This practice has led to the “confidential witness problem” in securities litigation. [read post]
24 Apr 2007, 1:54 am
Lockheed Martin Corp., 2007 U.S. [read post]
29 Aug 2022, 9:05 pm
., across party lines) to issue a complaint to block Lockheed Martin’s vertical acquisition of Aerojet Rocketdyne, in what would have been the FTC’s first defense industry merger litigation in decades.6 Several weeks later, the parties abandoned the transaction, due, in part, to the FTC’s lawsuit.7 The DOJ’s pending litigation of UnitedHealth’s proposed acquisition of Change Healthcare and the FTC’s ongoing review of… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
23 Jan 2009, 1:00 am
(Managing Intellectual Property) (Law360) (Out-Law) Global Global - General Barack Obama and US IP Policy, IP litigation and share price, IP Strategy and open innovation – IP Think Tank podcast 19 January 2009 (IP Think Tank) Three ways to maintain your IP intelligence edge in lean times (Thomson Reuters Scientific) International standards organisation solicits views on improving the intangible valuation process (IAM) What is an IP strategist? [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks… [read post]
23 Feb 2010, 6:16 am
Of particular note, in December, the Securities and Exchange Commission (”SEC”) adopted new proxy disclosure rules that likely will be a focal point for public company directors, as the new rules relate to disclosures regarding the composition and operation of boards of directors. [1] This memorandum is an update of our client alert covering considerations for public company directors in the current environment issued on October 15, 2009. 1. [read post]
